FICCI today announced the Winners of its first R&D Awards. The FICCI R&D Awards is an effort towards recognizing the best of Indian innovative spirit to bring state-of-the-art product and services to the market through indigenous research and development activity. The Awards ceremony shall be held as a part of FICCI’s Global R&D Summit on November 12, 2104 at New Delhi.
The call for applications under FICCI R&D Awards was made for 2 categories, the Catapult Awards (for Indian entities with less than 3 years in business and/or less than INR 3 Crores in average annual turnover) and the R&D Awards (for other Indian entities). A total of 97 applications were received across both categories, and after initial short-listing, 32 applications were presented to a distinguished jury for picking the Winners.
The Winners of the first edition of the FICCI R&D Awards are:
- Project Akash Group- DRDL, DRDO for “Development and production of indigenous surface to air missile system – Akash”
- Perfint Healthcare Pvt Ltd. for “MAXIO - Integrated Visualization, Treatment Planning and Robotic Navigation for CT Guided Tumour Ablation”
The winners shall be honoured with a trophy and a cash award of INR 5 Lacs each. The Winners shall be felicitated by Shri Kalraj Mishra, Hon’ble Minister of MSME, Government of India during the Inaugural Session of the Global R&D Summit on Nov 12, 2014.
The Committee did not award any application the Catapult Award as the criteria was not met by the applicants.
The FICCI R&D Awards is slated to be an annual event coinciding with FICCI’s Global R&D Summit. FICCI wishes the Winners of the first edition of its R&D Awards the very best in their endeavours.
FICCI R&D Award Winners’ Profile: DRDL, DRDO Defence Research and Development Laboratory (DRDL) is a multi-disciplinary Missile System laboratory with thrust on design, development and flight evaluation of various types of Missile Systems for armed forces. Right form conceptualization of the weapon system to production and induction into services, the laboratory has capabilities and the state of art infrastructure in terms of facilities and human resource. The laboratory is ISO 9001: 2000 Certified. Design, Develop and lead to production cost effective guided weapon systems of assured Quality and Reliability with continual improvement, meeting the safety standards and time schedules.
AAKASH MISSILE SYSTEMS The supersonic surface to air missile ‘AKASH’ developed by DRDL, DRDO has a range of about 25km and carries fragmentation warhead which is triggered by radio proximity fuse. The missile uses state-of-art-technology integral ramjet rocket propulsion system and the onboard digital autopilot ensures stability and maneuvers. The multi function phased array radar tracks the targets and guides missiles towards them. The weapon system has a network of radar sensors to effectively manage the air threats. Production orders worth Rs 23,000 Cr were placed by Indian armed forces on Akash and offshoots of Akash missile system. Indian industry is continuously producing the system and delivering it to users IAF/IA. Three Squadrons of IAF and two Troops of AMS (worth Rs 4500 Cr) have been produced by Indian industry and delivered to IAF/IA.
PERFINT HEALTHCARE Perfint Healthcare is an Indian medical devices company designing and manufacturing planning and targeting solutions for image guided interventional procedures with emphasis on oncology and pain care. Started in 2005 by Healthcare professionals, Perfint is today the ‘world’s No.1 targeting solutions company’ with its patented products in over a hundred locations across the globe. Perfint have received various prestigious recognitions for developing and commercializing these products. Perfint is head quartered in Chennai, India and has an Advanced Technology Labs in Seattle, USA.
MAXIO:
MAXIO, the flagship product of Perfint is a multifunctional, interactive robotic system specifically designed to allow clinicians visually plan, execute, and validate interventional procedures on a single system and is being used by radiologists around the world for biopsy, drug delivery, ablation, drainage and fine needle aspiration. Studies conducted using MAXIO indicate improved treatment accuracy, reduced X-radiation to patients and minimal number of interventions.
No comments:
Post a Comment